Fig. 1From: Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver diseaseEffect of Policosanol, Atorvastatin, and Silymarin treatments on serum. a Total protein, b Albumin in HFD-fed animals. All values are represented as mean ± SD (n = 6). @@@p < 0.001 as compared with normal control animals; ***p < 0.001 as compared with HFD groupBack to article page